TOP 10 | CEOs IN HEALTHCARE & HEALTHTECH
01
WATCH NOW
Our commitment in serious kidney diseases
TO READ MORE TOP 10s, CLICK HERE
Reshma Kewalramani
Revenue: US $ 12bn Company: Vertex Pharmaceuticals Founded: 1989
Serving as CEO and President of Vertex, a Fortune 500 biotech giant, Reshma joined the company in 2017 following several years working as an internist and nephrologist. Under her leadership, Vertex has made considerable healthcare breakthroughs, including the development of five approved cystic fibrosis medicines and landmark approvals for JOURNAVX and CASGEVY. Since 2017, the company has more than doubled its employees and medicines and expanded its R & D pipeline and global reach. In addition to her position at Vertex, Reshma serves on multiple biomedical and academic boards, including the Biomedical Science Careers Program Board and the Boston University Chobanian & Avedisian School of Medicine Dean’ s Advisory Board. businesschief. com 43